Bioinformatics-based prediction and screening of immunogenic epitopes of Toxoplasma gondii rhoptry proteins 7, 21 and 22 as candidate vaccine target

dc.contributor.authorAyub, Fariha
dc.contributor.authorAhmed, Haroon
dc.contributor.authorSohail, Tehreem
dc.contributor.authorShahzad, Khuram
dc.contributor.authorCelik, Figen
dc.contributor.authorWang, Xu
dc.contributor.authorCao, Jianping
dc.date.accessioned2026-08-12T16:58:00Z
dc.date.issued2023
dc.departmentFırat Üniversitesi
dc.description.abstractIntroduction: Toxoplasmosis is a well-known zoonotic disease caused by Toxoplasma gondii. The main causes of the disease range from eating undercooked or contaminated meat and shellfish to cleaning litter trays into which cats that excreted toxoplasma via faeces. This pathogen can live for a very long time, possibly a lifetime, within the bodies of humans and other animals. Aims and objectives: This study aimed to predict and analyse candidate immunogenic epitopes for vaccine development by evaluating the physio-chemical properties, multiple sequence alignment, secondary and tertiary structures, phosphorylation sites, transmembrane domains, and signal peptides, of T. gondii rhoptry proteins ROP7, ROP21, and ROP22 using bioinformatics tools. Methods: To find immunogenic epitopes of rhoptry proteins, numerous bioinformatics web servers were used containing multiple sequence alignment, physiochemical properties, antigenicity and allergenicity, post-translational modification sites (PTMs), signal peptides, transmembrane domains, secondary and tertiary structures, and screening of predicted epitopes. We evaluated immunogenic linear B-cell epitopes as candidate proteins for vaccine development. Results: Nine epitopes were identified for each protein, and analysis of immunogenicity, revealed three candidate epitopes for ROP7, one for ROP21, and four for ROP22. Among all candidate epitopes, ROP22 contained the most immunogenic epitopes with immunogenicity score of 0.50575. Conclusion: We acquired detailed information on predicted immunogenic epitopes using in-silico methods. The results provide a foundation for further experimental analysis of toxoplasmosis, and potential vaccine development.
dc.description.sponsorshipNational Natural Science Foundation of China [81971969, 82272369]
dc.description.sponsorshipFunding This work was supported by grants from the National Natural Science Foundation of China [grant numbers 81971969 and 82272369 to J.C.] . The funders had no role in the study design, the data collection and analysis, the decision to publish, or the preparation of the manuscript.
dc.identifier.doi10.1016/j.heliyon.2023.e18176
dc.identifier.issn2405-8440
dc.identifier.issue7
dc.identifier.orcid0000-0002-2333-1684
dc.identifier.orcid0000-0002-5193-9697
dc.identifier.orcid0000-0002-2188-0196
dc.identifier.orcid0000-0002-2996-9152
dc.identifier.orcid0000-0002-1974-0047
dc.identifier.pmid37519638
dc.identifier.scopus2-s2.0-85165994546
dc.identifier.scopusqualityQ1
dc.identifier.urihttps://doi.org/10.1016/j.heliyon.2023.e18176
dc.identifier.urihttps://hdl.handle.net/11508/46678
dc.identifier.volume9
dc.identifier.wosWOS:001043039800001
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherCell Press
dc.relation.ispartofHeliyon
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WoS_20260511
dc.subjectToxoplasma gondii
dc.subjectRhoptry proteins
dc.subjectROP7
dc.subjectROP21
dc.subjectROP22
dc.subjectBioinformatics
dc.subjectVaccine
dc.subjectEpitope
dc.titleBioinformatics-based prediction and screening of immunogenic epitopes of Toxoplasma gondii rhoptry proteins 7, 21 and 22 as candidate vaccine target
dc.typeArticle

Dosyalar